Medroxyprogesterone acetate causes the alterations of endoplasmic reticulum related mRNAs and lncRNAs in endometrial cancer cells

被引：0
|
作者：
Wenjiao Cao
Wuyuan Gao
Panchan Zheng
Xiao Sun
Lihua Wang
机构：
[1] Shanghai Jiaotong University,Department of Obstetrics and Gynecology, the International Peace Maternity & Child Health Hospital of China Welfare Institute (IPMCH)
[2] Shanghai Jiao Tong University,The International Peace Maternity and Child Health Hospital, School of Medicine
[3] Shanghai Key Laboratory of Embryo Original Diseases,undefined
[4] Shanghai Municipal Key Clinical Specialty,undefined
来源：
BMC Medical Genomics | / 12卷
关键词：
Endometrial cancer; Medroxyprogesterone acetate; Endoplasmic reticulum stress; CHOP; Lnc-CETP-3;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Efficacy and prognosis of adjuvant treatment of endometrial cancer with medroxyprogesterone acetate COX regression analysis
    Wang, Ding-Ran
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (23) : 5447 - 5454
  • [32] Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer
    Yunokawa, Mayu
    Yoshida, Hiroshi
    Watanabe, Reiko
    Noguchi, Emi
    Shimomura, Akihiko
    Shimoi, Tatsunori
    Yonemori, Kan
    Shimizu, Chikako
    Fujiwara, Yasuhiro
    Tamura, Kenji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (01) : 127 - 134
  • [33] Growth effects of raloxifene, estradiol, medroxyprogesterone acetate, and progesterone on human endometrial adenocarcinoma cells
    Boonstanfar, R
    Amezcua, CA
    Tourgeman, DE
    Roy, S
    Felix, JC
    Stanczyk, FZ
    FERTILITY AND STERILITY, 2003, 79 (01) : 223 - 225
  • [34] COMPARISON OF MASS-SPECTROMETRY AND RADIOIMMUNOASSAY TO MEASURE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ENDOMETRIAL CANCER
    KARKKAINEN, J
    VESTERINEN, E
    STENMAN, UH
    ADLERCREUTZ, H
    NIEMINEN, U
    WIDHOLM, O
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (09) : 975 - 977
  • [35] MEDROXYPROGESTERONE ACETATE (MPA) MAINTENANCE THERAPY TO TREAT RECURRENT ENDOMETRIAL CANCER: CASE REPORTS
    Nagano, H.
    Furukawa, Y.
    Tachibana, Y.
    Akazawa, M.
    Ueno, M.
    Ichinoe, M.
    Hashimoto, K.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A349 - A350
  • [36] Allred score is a promising predictor of prognosis and medroxyprogesterone acetate efficacy in patients with endometrial cancer
    Mayu Yunokawa
    Hiroshi Yoshida
    Reiko Watanabe
    Emi Noguchi
    Akihiko Shimomura
    Tatsunori Shimoi
    Kan Yonemori
    Chikako Shimizu
    Yasuhiro Fujiwara
    Kenji Tamura
    Cancer Chemotherapy and Pharmacology, 2017, 80 : 127 - 134
  • [37] AN ANALYSIS OF RESPONSE TO MEDROXYPROGESTERONE ACETATE IN CHEMO-NAIVE RECURRENT/METASTATIC ENDOMETRIAL CANCER
    Bashir, F.
    Iqbal, M.
    El-Mahdawi, N.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1403 - 1403
  • [38] INHIBITORY EFFECTS OF DANAZOL AND MEDROXYPROGESTERONE ACETATE ON [H-3]THYMIDINE INCORPORATION IN HUMAN ENDOMETRIAL CANCER-CELLS
    TERAKAWA, N
    IKEGAMI, H
    SHIMIZU, I
    INOUE, M
    TANIZAWA, O
    MATSUMOTO, K
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1988, 31 (01): : 131 - 135
  • [39] Cytokine activity in cancer-related anorexia/cachexia:: Role of megestrol acetate and medroxyprogesterone acetate
    Mantovani, G
    Macciò, A
    Lai, P
    Massa, E
    Ghiani, M
    Santona, MC
    SEMINARS IN ONCOLOGY, 1998, 25 (02) : 45 - 52
  • [40] EVOLUTION OF PHENOBARBITAL-INDUCED ALTERATIONS IN ENDOPLASMIC RETICULUM OF HEPATIC PARENCHYMAL CELLS
    ERICSSON, JL
    ORRENIUS, S
    JOURNAL OF ULTRASTRUCTURE RESEARCH, 1966, 14 (3-4): : 418 - &
12345